Loading...
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study
OBJECTIVE: To assess the efficacy of recombinant human erythropoietin (rhEPO) in amyotrophic lateral sclerosis (ALS). METHODS: Patients with probable laboratory-supported, probable or definite ALS were enrolled by 25 Italian centres and randomly assigned (1:1) to receive intravenous rhEPO 40 000 IU...
Na minha lista:
| Udgivet i: | J Neurol Neurosurg Psychiatry |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4515982/ https://ncbi.nlm.nih.gov/pubmed/25595151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2014-308996 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|